Dr. Behcet Uz Children's Hospital
Izmir, Konak, 35000, Turkey (Türkiye)
NCT Number: NCT06970418
This study aims to explore chronotype and sleep disturbances in ADHD subtypes and their relation to functional impairment.
Looking for future studies?
Notify Me7 year–12 year
All sexes
Observational
Izmir, Konak, 35000, Turkey (Türkiye)
The goal of this observational study is to compare morningness-eveningness and sleep disturbances between children diagnosed with Restrictive ADHD (ADHD-R) and those with Predominantly Inattentive ADHD (ADHD-PI), and to examine how these sleep-related features impact functional impairment.The main question it aims to answer is:Are chronotype differences and sleep disturbances associated with greater functional impairment in children with ADHD-R compared to ADHD-PI and typically developing peers?
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: At baseline (upon enrollment)
Total Score on the Children's Sleep Habits Questionnaire (CSHQ) - Short Form Sleep habits and sleep-related problems will be assessed using the Children's Sleep Habits Questionnaire (CSHQ) - Short Form, a 33-item parent-report measure. Items are rated based on the child's behavior over the past week. Each item is scored from 1 to 3, with higher scores indicating more frequent sleep problems. Items 32 and 33 are scored on a 0-2 scale, and items 1, 2, 3, 10, 11, and 26 are reverse-coded. The total score ranges from 33 to 97. A score of 41 or higher is considered clinically significant, indicating problematic sleep.
Time Frame: At baseline (upon enrollment) Units of Measure: Total score (range: 33-97) Interpretation: Higher scores indicate more severe sleep problems.
Time frame: At baseline (upon enrollment)
Chronotype preference will be assessed using the Children's Chronotype Questionnaire (CCQ), a parent-report tool adapted from the Munich Chronotype Questionnaire and the Children's Morningness-Eveningness Scale. Items 17-26 determine the chronotype score; items 17, 18, 24, and 25 are reverse-coded. Total scores classify children as morning-type (≤23), intermediate-type (24-32), or evening-type (≥33).
Units of Measure: Chronotype type; total score (range: 10-40); average sleep duration (hours). Higher scores reflect stronger eveningness preference.
Time frame: At baseline (upon enrollment)
Functional impairment will be assessed using the Weiss Functional Impairment Rating Scale - Parent Form (WFIRS-P), a 50-item Likert-type questionnaire completed by parents. The scale includes six domains: family, school, life skills, self-concept, social activities, and risky behaviors. Each item is rated from 0 ("never") to 3 ("very often"), based on the child's functioning over the past month. Subscale and total scores are calculated by summing item scores and dividing by the number of completed items. Functional impairment in a domain is defined as either scoring 3 on at least one item, 2 on two items, or having a mean score of 1.5 or higher in that domain. overall functional impairment.
Higher scores indicate greater functional impairment.
Dr. Behcet Uz Children's Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06679010
Anxiety, Anxiety Disorders
Odense, Denmark
View Trial DetailsNCT01876524
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Cartagena, Murcia, Spain
View Trial DetailsNCT02364817
Alcohol-Related Disorders, Alcoholism
Bron, France
View Trial DetailsNCT07253441
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity
Lenexa, Kansas, United States
View Trial Details